Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Treasury Shares (2020 - 2026)

SkinHealth Systems has reported Treasury Shares over the past 6 years, most recently at $12.3 million for Q4 2025.

  • Quarterly Treasury Shares rose 69.71% to $12.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.3 million through Dec 2025, up 69.71% year-over-year, with the annual reading at $12.3 million for FY2025, 69.71% up from the prior year.
  • Treasury Shares was $12.3 million for Q4 2025 at SkinHealth Systems, up from $10.7 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $12.3 million in Q4 2025 and troughed at $210000.0 in Q2 2021.
  • The 5-year median for Treasury Shares is $2.6 million (2022), against an average of $3.7 million.
  • Year-over-year, Treasury Shares surged 973.35% in 2022 and then crashed 68.37% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $380775.0 in 2021, then skyrocketed by 577.61% to $2.6 million in 2022, then skyrocketed by 103.19% to $5.2 million in 2023, then surged by 38.37% to $7.3 million in 2024, then soared by 69.71% to $12.3 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Treasury Shares are $12.3 million (Q4 2025), $10.7 million (Q3 2025), and $2.8 million (Q2 2025).